Personal profile


Dr David Metz is a paediatric nephrologist, paediatric clinical pharmacologist and clinician-researcher. His PhD investigated methods to increase precision in mycophenolic acid dosing in kidney transplantation, through clinical trial and pharmacometric analysis. His research continues in this field, alongside active translation into clinical care. He is also medical lead of the Monash Children’s Clinical Trial Centre at Monash Health, which is involved in both commercial and investigator-initiated therapeutic trials to increase access to, and improve safety and effectiveness of, therapeutic drugs used in children.

Research interests

Individualised dosing of immunosuppressants and other critical dose drugs.

Paediatric clinical pharmacology and optimal usage of therapeutic drugs to increase safety and effectiveness in children.

Clinical activities

Paediatric nephrologist, clinical lead in haemodialysis and therapeutic plasma exchange.

Education/Academic qualification

Transplant Immunosuppression; Clinical Pharmacology, PhD, Optimising immunosuppressant dosing in kidney transplantation: better outcomes through quantitative pharmacology, University of Melbourne

20148 Jul 2021

Award Date: 8 Jul 2021

Bachelor of Medicine, Bachelor of Surgery, MBBS

External positions

Medical Lead, Monash Children's Clinical Trial Centre, Monash Children's Hospital

Paediatric Nephrologist, Royal Children's Hospital Melbourne

Research area keywords

  • Pharmacokinetics
  • Kidney Transplant
  • Pharmacology
  • Optimisation of Dosing
  • Paediatrics
  • Nephrology

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or